MedQuist Inc., of Mt. Laurel, N.J., appointed John Simmons independent board member.
Nonlinear Dynamics Ltd., of Newcastle Upon Tyne, UK, promoted Steve Noblitt to U.S. sales manager.
Nuvelo Inc., of Sunnyvale, Calif., appointed Kimberly Popovits to its board.
Orion Genomics, of St. Louis, appointed Jorge Leon to its board.
Osteologix Inc., of San Francisco, appointed Bobby Sandage to its board.
PDI Inc., of Saddle River, N.J., appointed Craig Burton and Doug Case to the business development team.
PharmaMar SA, of Madrid, Spain, appointed Pedro Santabarbara senior director of the clinical development department.
Protalex Inc., of New Hope, Pa., appointed Victor Sloan senior vice president and chief medical officer.
QuatRx Pharmaceuticals Co., of Ann Arbor, Mich., appointed Jeffery Brinza general counsel.
Quintiles Transnational Corp., of Research Triangle Park, N.C., appointed Kiyotaka Fujii president and CEO of Quintiles Transnational Japan K.K.
Renovis Inc., of South San Francisco, appointed Judith Hemberger to its board.
SciGene, of Sunnyvale, Calif., appointed Stuart Lacock vice president of North American sales.
Southern Research Institute, of Birmingham, Ala., appointed Maurizio Grimaldi to its drug discovery team.
Stem Cell Therapeutics Corp., of Calgary, Alberta, appointed James DeMesa to its board.
Tm Bioscience Corp., of Toronto, appointed Trevor Hawkins to its board.
U.S. BioDefense, of City of Industry, Calif., appointed Cyndi Chen director of stem cell research.
VaxGen Inc., of Brisbane, Calif., appointed Eve Slater and Kevin Reilly to its board.
Vertex Pharmaceuticals Inc., of Cambridge, Mass., appointed Lewis Cantley to its scientific advisory board.
ViaCell Inc., of Boston, appointed Paul Blake and James Sigler to its board.
VioQuest Pharmaceuticals Inc., of Monmouth Junction, N.J., appointed Richard Welter vice president of corporate business development.
Xillix Technologies Corp., of Richmond, British Columbia, appointed Rob Ngungu vice president, quality, clinical and regulatory affairs.
XOMA Ltd., of Berkeley, Calif., appointed Alan Solinger vice president of clinical immunology.
ZymoGenetics Inc., of Seattle, appointed Nicole Onetto chief medical officer and senior vice president.